Tuesday, October 13, 2009 9:32:23 AM
Oct 13, 2009 9:30:00 AM
Copyright Business Wire 2009
Energy-Saving Glass Using Heat Mirror Suspended Film Technology to Be Produced by Southwall Joint Venture
PALO ALTO, Calif.--(BUSINESS WIRE)-- Southwall Technologies Inc. (OTCBB:SWTX), the worldwide innovator of energy-saving films and glass products, announced today that it will supply the high performance insulating glass for InnovisionTM Windows, a new line of residential and commercial-grade fiberglass windows introduced last week by Owens Corning, Inc., the world's leading manufacturer of fiberglass insulation and building materials. Southwall Insulating Glass, a joint venture company formed by Southwall last year to streamline the production of super-insulating glass incorporating Heat Mirror suspended film technology, will manufacture the glass for Owens Cornings' newest window family.
Innovision windows' combination of Heat Mirror insulating glass - honored by Popular Science magazine as one of the top 100 inventions of the millennium - with the industry's first fully-bonded, slim-line fiberglass frame delivers a lightweight window with maximum strength and durability, a larger glass area, and superior energy efficiency.
"Because fiberglass technology enables the strongest and most energy-efficient frames available, it made perfect sense for Owens Corning to choose Southwall's Heat Mirror suspended film technology, which enables the most energy-efficient glass available," said Bruce Lang, president of Southwall Insulating Glass.
Bringing Super-Insulating Glass to Mainstream Green Building
Because glass remains a weak link in saving energy in buildings and homes, the US Department of Energy (DOE) is phasing in more demanding Energy StarTM window performance standards starting in 2010. Just as the window industry made a fundamental shift to low-e coated glass technology in response to the first Energy Star standards, the industry is now making a similar shift to super-insulating, multi-cavity glass technology to reach a new level of energy efficiency. The DOE's higher performance targets and aggressive implementation timeline have created increased interest in available and proven solutions such as Heat Mirror insulating glass.
"National window brands are demanding more energy-efficient glass to meet increasing energy standards, and Heat Mirror technology promises to be a key enabler for a new generation of lightweight and super-insulating windows," added Dennis Capovilla, president and CEO of Southwall Technologies. "We are extremely pleased that a strong brand such as Owens Corning is partnering with us to bring the benefits of Heat Mirror technology to a broader audience."
About Heat Mirror Suspended Film Technology
Heat Mirror glass is a superior multi-cavity solution that suspends one or more low-emissivity and solar-reflective Heat Mirror films inside of an insulating glass unit to create two, three or even four insulating cavities without adding weight. This innovative approach enables window fabricators to offer higher performance glass options for their existing window systems today as well as for next-generation window systems in development. Heat Mirror suspended film technology combines the best of film-based and glass-based technologies to create the industry's first "super glass" with center-of-glass insulating performance ranging from R-6 to R-20 while minimizing solar heat gain and blocking UV radiation.
About Southwall Technologies
Southwall Technologies Inc. is recognized as a leader in the development and manufacture of high performance, energy-saving films and glass products that dramatically improve the energy efficiency of residential, commercial and automotive glass. Southwall is an ISO 9001:2000-certified manufacturer with customers in over 25 countries.
Recent SWTX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:26:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:05:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:09:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:05:26 PM
- FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN • GlobeNewswire Inc. • 08/28/2024 10:30:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:36:23 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:34:23 AM
- SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 08/07/2024 10:30:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:45 PM
- SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors • GlobeNewswire Inc. • 07/29/2024 10:30:11 AM
- SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 • GlobeNewswire Inc. • 07/23/2024 11:00:02 AM
- Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm • PR Newswire (US) • 07/02/2024 04:49:00 PM
- SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN • GlobeNewswire Inc. • 07/01/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:07:38 PM
- SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/05/2024 11:00:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:37:20 PM
- SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:53:56 PM
- SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference • GlobeNewswire Inc. • 05/08/2024 11:00:27 AM
- SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates • GlobeNewswire Inc. • 05/02/2024 10:30:00 AM
- SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 05:31:32 PM
- SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 • GlobeNewswire Inc. • 04/18/2024 11:00:28 AM
- SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN • GlobeNewswire Inc. • 03/04/2024 11:30:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:16:11 PM
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM